IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients
NCT ID: NCT01886456
Last Updated: 2013-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
210 participants
INTERVENTIONAL
2013-02-28
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Values for IOP will be measured at baseline, 1 day and 1 month post-interventional as well as 2, 3, 6, 9, 12, 18 and 24 months after treatment.
* Trial with medical device
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients
NCT01467388
Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma
NCT01383525
Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree
NCT06851546
The Efficacy of Selective Laser Trabeculoplasty
NCT00347893
Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines
NCT01467440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PLT
patients treated with patterned laser trabeculoplasty
Laser trabeculoplasty
SLT
patients treated with selective laser trabeculoplasty
Laser trabeculoplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laser trabeculoplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* visible angle structures over 360° on gonioscopy
* age = 18 years
Exclusion Criteria
* patients who underwent refractive corneal surgery for any reason or who underwent ocular surgery to reduce intraocular pressure (e.g. trabeculectomy)
* monocle situation
* anterior chamber lenses (incl. iris claw)
* secondary glaucoma (with the exception of pseudoexfoliation and pigment dispersion)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Kniestedt, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Ophthalmology Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Ophthalmology Clinic
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Rolim-de-Moura CR, Paranhos A Jr, Loutfi M, Burton D, Wormald R, Evans JR. Laser trabeculoplasty for open-angle glaucoma and ocular hypertension. Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD003919. doi: 10.1002/14651858.CD003919.pub3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14.1.2013_KEK ZH 2012-0422
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.